| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.09 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |